Goldman Sachs projects positive 2022 for big insurers

Goldman Sachs analysts gave ‘buy’ ratings to five of the 10 publicly traded health insurers it now covers. Just one got a ‘sell’ rating.


You may also like

Brent crude oil

Brent crude oil

Crude oil

Crude oil